Toll Free Number Toll Free: 1800 103 1369 Email Us Email Us: customercare@canmoney.in
Market


Income Statement

You can view the Income Statement for the last 5 years.



INCOME STATEMENT

Aarey Drugs & Pharmaceuticals Ltd.

GO
Market Cap. ( ₹ in Cr. ) 309.06 P/BV 2.04 Book Value ( ₹ ) 53.38
52 Week High/Low ( ₹ ) 115/50 FV/ML 10/1 P/E(X) 77.91
Book Closure 30/09/2024 EPS ( ₹ ) 1.40 Div Yield (%) 0.00
(₹ in Crs.)

ParticularsMar 26Mar 25Mar 24Mar 23Mar 22
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)PRARARARAR
FaceValue10.0010.0010.0010.0010.00
      
      
INCOME     
Revenue From Operations [Net]472.27473.94395.62418.96492.68
Total Operating Revenues472.27473.94395.62418.96492.68
      
Other Income6.109.816.962.732.75
Total Revenue478.37483.76402.58421.69495.43
      
EXPENSES     
Cost Of Materials Consumed450.560.000.000.000.00
Purchase Of Stock-In Trade0.00472.87387.76418.98467.29
Changes In Inventories Of FG,WIP And Stock-In Trade3.94-10.80-5.86-15.144.78
Employee Benefit Expenses0.760.810.720.810.98
Finance Costs5.004.664.382.872.00
Depreciation And Amortisation Expenses2.851.941.701.571.99
Other Expenses9.838.188.556.588.37
Total Expenses472.95477.65397.24415.68485.40
      
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax5.416.105.346.0110.03
      
Profit/Loss Before Tax5.416.105.346.0110.03
      
Tax Expenses-Continued Operations     
Current Tax1.451.401.321.782.61
Deferred Tax0.000.17-0.67-0.04-0.11
Tax For Earlier Years0.000.510.000.500.98
Total Tax Expenses1.452.080.662.243.48
Profit/Loss After Tax And Before ExtraOrdinary Items3.974.024.683.776.54
      
Profit/Loss From Continuing Operations3.974.024.683.776.54
      
Profit/Loss For The Period3.974.024.683.776.54
      
OTHER INFORMATION     
      
EARNINGS PER SHARE     
Basic EPS (Rs.)1.391.421.671.492.72
Diluted EPS (Rs.)1.391.421.671.492.72